Gerardo Gatti Selected Research

Toll-Like Receptors (Toll-Like Receptor)

1/2022	Oral squamous cell carcinoma (OSCC) tumors from heavy alcohol consumers are associated with higher levels of TLR9 and a particular immunophenotype: Impact on patient survival.
12/2006	Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerardo Gatti Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 11/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2006
2	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Melanoma (Melanoma, Malignant) 07/2013
1	Carcinoma (Carcinomatosis) 07/2013
1	Prostatic Neoplasms (Prostate Cancer) 09/2009
1	Adenocarcinoma 09/2009
1	Infections 12/2006
1	Chlamydia Infections 12/2006

Drug/Important Bio-Agent (IBA)

3	Poly A-UIBA 01/2019 - 07/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 12/2006
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2021
2	Toll-Like Receptor 4IBA 09/2009 - 11/2007
2	CytokinesIBA 09/2009 - 12/2006
2	LipopolysaccharidesIBA 11/2007 - 05/2006
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Diazepam (Valium)FDA LinkGeneric 01/2021
1	EnzymesIBA 07/2020
1	Caseins (Casein)FDA Link 07/2020
1	TrypsinIBA 07/2020
1	N-isopropylacrylamideIBA 07/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Toll-Like Receptor AgonistsIBA 03/2016
1	Double-Stranded RNA (RNA, Double Stranded)IBA 07/2013
1	Poly I-CIBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 11/2007
1	ChemokinesIBA 12/2006

Therapy/Procedure

6	Therapeutics 04/2021 - 11/2007
3	Immunotherapy 01/2019 - 07/2013